No abstract available.
Umbilical Cord*

No abstract available.
Endometriosis* ; Female

BACKGROUND: Recently elderly people have increased in Korea and increased demands of medical service. This study was carried out to identify diseases and health service utilization patterns of geriatric inpatients to provide better understanding and basis planning to meet the needs of expanding geriatric population. METHOD: We use data of `Patient Survey in Korea` in 1999 and analyzed characteristics of disease structure and utilization patterns of health care service of 54,013 cases of discharged patients aged 65 years or more. RESULT: The proportion of the elderly in total discharged patients is 14.7%. Male to female ratio is 1:1.3 and most common age group was between 65 and 69 years old. 84.2% of elderly patients were admitted at secondary or tertiary health care facilities. The most common disease in geriatric inpatients is malig- nancy in male and vascular disease in female. The average duration of hospitalization is 14.2 days. They stay longer than the nation wide average hospital length and stay longest when they are admitted by mental and behavioral disorders. CONCLUSION: Geriatric patients are admitted mostly with chronic degenerative diseases such as neoplasm and vascular disease. Elders prefer to be admitted to tertiary hospitals and oriental hospitals. They stay more in hospital.
Aged ; Delivery of Health Care ; Female ; Health Services* ; Hospitalization ; Humans ; Inpatients* ; Korea ; Male ; Tertiary Care Centers ; Vascular Diseases

No abstract available.
Child* ; Colon* ; Constipation* ; Enema* ; Fecal Incontinence* ; Humans

PURPOSE: We assessed the impact of pelvic lymphadenectomy on the survival of patients who had undergone radical cystectomy. MATERIALS AND METHODS: We retrospectively reviewed 107 patients who underwent radical cystectomy for transitional cell carcinoma of the bladder between January 1991 and December 2000. We preoperatively excluded patients with evidence of pelvic lymphadenopathy and distant metastases from the study. Among 107 patients, 61 patients (Group A) underwent pelvic lymphadenectomy while 46 patients (Group B) did not. The clinicopathological parameters were not significantly different in the two groups. RESULTS: In group A, 12 patients (19.6%) were found to have pelvic node metastases. Five-year overall survival and recurrence-free survival rates were 68% and 75% for Group A, respectively. In group B, 5-year overall survival and recurrence-free survival rates were 36% and 56%, respectively. Multivariate analysis revealed that T stage (p=0.004) and lymphadenectomy (p=0.044) were significant prognostic factors for survival. CONCLUSIONS: The overall survival rates between the two groups were significantly different. Our findings suggested that lymphadenectomy may improve the prognosis of patients who underwent radical cystectomy for transitional cell carcinoma of the bladder.
Carcinoma, Transitional Cell* ; Cystectomy* ; Humans ; Lymph Node Excision* ; Lymphatic Diseases ; Multivariate Analysis ; Neoplasm Metastasis ; Prognosis ; Retrospective Studies ; Survival Rate ; Urinary Bladder Neoplasms ; Urinary Bladder*

No abstract available.
Burkholderia cepacia* ; Skin*

No abstract available.
Coronary Vessels* ; Electrocardiography* ; Spasm*

No abstract available.
Coronary Vasospasm* ; Heart Arrest* ; Verapamil*

PURPOSE: Survivin, a novel inhibitor of apoptosis(IAP), is expressed in many human cancers, but its potential role in prostate cancer is unknown. The expressions of survivin in benign prostate hyperplasia, localized prostate cancer and metastatic prostate cancer were investigated. MATERIALS AND METHODS: Immunohistochemical staining of paraffin sections by a monoclonal antibody for survivin using the standard avidin- biotin-peroxidase technique was performed in 19, 20 and 30 cases with benign prostate hyperplasia, localized prostate cancer and metastatic prostate cancer, respectively. The relationships between the expression of survivin and the clinicopathological characteristics were analyzed. RESULTS: No survivin expression was found in benign prostate hyperplasia, but not in prostate cancer. The expression of survivin was observed in the cytoplasm of the tumor cells, but not in the neighboring normal tissues. The immunoreactivity of survivin increased from localized prostate cancer (60.0%) to metastatic prostate cancer(76.7%), but did not differ significantly. A statistically significant association was observed between the expression of survivin and the Gleason score(p=0.001). CONCLUSIONS: Survivin is expressed in the majority of Prostate cancers and is related to the Gleason score. Survivin may be a potential target for apoptosis-based therapy.
Apoptosis ; Cytoplasm ; Humans ; Hyperplasia* ; Neoplasm Grading ; Paraffin ; Prostate* ; Prostatic Neoplasms*

No abstract available.
Chin* ; Hemangioma*